Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001130319-09-000093
Filing Date
2009-02-19
Accepted
2009-02-18 21:18:34
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K o42761e10vk.htm 10-K 1384345
2 EX-23.1 o42761exv23w1.htm EX-23.1 1567
3 EX-31.1 o42761exv31w1.htm EX-31.1 9323
4 EX-32.1 o42761exv32w1.htm EX-32.1 3397
5 GRAPHIC o42761o4276101.gif GRAPHIC 6580
  Complete submission text file 0001130319-09-000093.txt   1409262
Mailing Address 101 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 101 COLLEGE ROAD EAST PRINCETON NJ 08540 609-228-8220
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51686 | Film No.: 09620011
SIC: 3841 Surgical & Medical Instruments & Apparatus